Dr. Vonderheide is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Boulevard
12-114 South
Philadelphia, PA 19104Phone+1 215-662-3929Fax+1 215-573-2652- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1998
Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
Harvard Medical SchoolClass of 1993
Certifications & Licensure
PA State Medical License 2001 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2007
Clinical Trials
- Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma Start of enrollment: 2010 Feb 01
- Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma Start of enrollment: 2012 Apr 01
- Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors Start of enrollment: 2005 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Advancing Cancer Interception.Susan M Domchek, Robert H Vonderheide> ;Cancer Discovery. 2024 Apr 4
- Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma.Lin, J. H., Il-Kyu Kim, Mark S Diamond, Salina Yuan, Samantha B Kemp, Benjamin M Kahn, Qinglan Li, Jeffrey H Lin, Jinyang Li, Robert J Norgard, Stacy K Thomas, Maria M...> ;Nature Communications. 2024 Feb 20
- Machine learning links T cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer.Katie E Blise, Shamilene Sivagnanam, Courtney B Betts, Konjit Betre, Nell Kirchberger, Benjamin Tate, Emma E Furth, Andressa Dias Costa, Jonathan A Nowak, Brian M Wolp...> ;Biorxiv. 2023 Oct 23
- Join now to see all
Journal Articles
- Unique Pattern of Neutrophil Migration and Function During Tumor ProgressionNeil Hockstein, Charles Mulligan, Robert H Vonderheide, Gregory Masters, Nature
- Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in CancerAndrew J Rech, Robert H Vonderheide, Jonathan J Kotzin, Clinical Cancer Research
Press Mentions
Two Penn Medicine Abramson Cancer Center Faculty Members Receive Top ASCO AwardsMay 23rd, 2023- AACR Annual Meeting 2023: Closing Plenary Highlights Research Breakthroughs and Next StepsMay 22nd, 2023
- AACR Annual Meeting 2023: Opening Plenary Covers Breadth of Cancer ResearchApril 25th, 2023
- Join now to see all
Grant Support
- Combined CD40 Activation And CTLA4 Blockade In MelanomaNational Cancer Institute2011–2012
- Immunoregulation And Immunotherapy Of Breast CancerNational Cancer Institute2005–2011
- Telomerase As A Widely Expressed Tumor AntigenNational Cancer Institute2001–2004
- Telomerase As A Widely Expressed Tumor AntigenNational Cancer Institute2000–2001
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
